Search research articles
Contact Us
Filters
Showing results (611-620 of 831) with videos related to
Page
of 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2024
Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application
Nicholas Mikolajewicz, Patricia P Yee, Debarati Bhanja, et al.
Nature
|
October 7, 2011
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A Opitz, Ulrike M Litzenburger, Felix Sahm, et al.
Neuro-Oncology
|
July 28, 2018
DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment
Hendrik Witt, Dorothee Gramatzki, Bettina Hentschel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2018
Diagnostic value of <sup>18</sup>F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
Fabian Wolpert, Michael Weller, Anna Sophie Berghoff, et al.
International Journal of Cancer
|
December 31, 2025
Conditional survival in glioblastoma: The evolution of prognostic factors over time
Timothy Mueller, Flavio Vasella, Julia Velz, et al.
The Lancet. Oncology
|
February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report
Terri S Armstrong, Linda Dirven, David Arons, et al.
The New England Journal of Medicine
|
March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastoma
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
Oncotarget
|
November 12, 2016
Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells
Lindsay C Spender, G John Ferguson, Sijia Liu, et al.
Neuro-Oncology
|
October 10, 2024
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1
Martin J van den Bent, Enrico Franceschi, Mehdi Touat, et al.
Neuro-Oncology
|
January 8, 2023
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival
Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, et al.
Page
of 84
Search research articles
Search
Showing results (611-620 of 831) with videos related to
Sort By:
Page
of 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2024
Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application
Nicholas Mikolajewicz, Patricia P Yee, Debarati Bhanja, et al.
Nature
|
October 7, 2011
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A Opitz, Ulrike M Litzenburger, Felix Sahm, et al.
Neuro-Oncology
|
July 28, 2018
DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment
Hendrik Witt, Dorothee Gramatzki, Bettina Hentschel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 21, 2018
Diagnostic value of <sup>18</sup>F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
Fabian Wolpert, Michael Weller, Anna Sophie Berghoff, et al.
International Journal of Cancer
|
December 31, 2025
Conditional survival in glioblastoma: The evolution of prognostic factors over time
Timothy Mueller, Flavio Vasella, Julia Velz, et al.
The Lancet. Oncology
|
February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report
Terri S Armstrong, Linda Dirven, David Arons, et al.
The New England Journal of Medicine
|
March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastoma
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
Oncotarget
|
November 12, 2016
Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells
Lindsay C Spender, G John Ferguson, Sijia Liu, et al.
Neuro-Oncology
|
October 10, 2024
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1
Martin J van den Bent, Enrico Franceschi, Mehdi Touat, et al.
Neuro-Oncology
|
January 8, 2023
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival
Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, et al.
Page
of 84